Venous Thromboembolism in IBD Not Linked to Increased Thrombophilia
Researchers investigated whether thrombophilia in patients with IBD significantly contributes to developing venous thromboembolic events.
Thromboembolism
BMI a Factor in Risk of Thromboembolic Events With Peripherally Inserted Central Catheters
A study sought to determine whether overweight/obesity is a factor in the development of thrombosis in cancer patients with peripherally inserted central catheters.
DOACs Cut Recurrent VTE in Adults With Cancer-Related Thrombosis
Direct oral anticoagulants reduce recurrent VTE events by 41 percent, with no significant increase in major bleeding, compared to dalteparin
Does Acute COVID-19 Infection Increase Long-Term Cardiovascular Risk?
Investigators sought to determine the risk and 1-year burdens for several cardiovascular outcomes in patients who survived acute COVID-19 infection.
Risk for Cancer Increased After VTE for Patients With Psoriasis
Standardized incidence ratio was 3.0 during first year of follow-up after VTE and decreased to 1.5 during subsequent years
Updated CHEST Guidelines on Antithrombotic Therapy in Venous Thromboembolism
The updated CHEST guideline on antithrombotic therapy for VTE includes 4 new PICO questions as well as updated recommendations based on newer evidence.
Low Forced Expiratory Volume in Chronic Thromboembolic Pulmonary Hypertension
Is there a significant relationship between obstructive impairment and the low forced expiratory volumes frequently seen in patients with CTEPH?
Can a Mobile Health Tech Program Help Patients With Atrial Fibrillation, Multimorbidity?
Researchers investigated whether a mobile health technology program for older adults with AF and multimorbidity would help decrease AF-related adverse events.
Pediatric-Onset IBD Associated With Increased Risk for VTE
Investigators examined the incidence of and risk factors for venous thromboembolism in pediatric patients with IBD compared with the general pediatric population.
Xarelto Approved to Treat and Prevent Blood Clots in Pediatric Patients
A new oral suspension formulation of Xarelto has also been approved by the FDA.
- Loading...
Loading...
Loading... 
Loading...